Zhou-pLOV-GFP-Luc
(Plasmid
#161030)
-
PurposeLentiviral vector expressing GFP and luciferase for use as a reporter in pseudovirus production and infection.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 161030 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonePLOV
-
Vector typeLentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameGFP and luciferase
-
SpeciesSynthetic
Cloning Information
- Cloning method Unknown
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://www.biorxiv.org/content/10.1101/2021.02.17.431647v1 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Zhou-pLOV-GFP-Luc was a gift from Dapeng Zhou (Addgene plasmid # 161030 ; http://n2t.net/addgene:161030 ; RRID:Addgene_161030) -
For your References section:
Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19. Tong J, Zhu C, Lai H, Feng C, Zhou D. Vaccines (Basel). 2021 Mar 22;9(3). pii: vaccines9030296. doi: 10.3390/vaccines9030296. 10.3390/vaccines9030296 PubMed 33810026